In some countries, this medicine may only be approved for veterinary use.
In the US, Cyclophosphamide (cyclophosphamide systemic) is a member of the drug class alkylating agents and is used to treat Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Cogan's Syndrome, Dermatomyositis, Endometrial Cancer, Ewing's Sarcoma, Histiocytosis, Hodgkin's Lymphoma, IgA Nephropathy, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neuroblastoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Organ Transplant - Rejection Prophylaxis, Osteosarcoma, Ovarian Cancer, Pemphigoid, Pemphigus, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Systemic Lupus Erythematosus, Systemic Sclerosis, Testicular Cancer, Wegener's Granulomatosus and Wilms' Tumor.
US matches:
- Cyclophosphamide
- Cyclophosphamide Tablets
- Cyclophosphamide oral/injection
- Cyclophosphamide Oral, Intravenous
- Cyclophosphamide Injection
UK matches:
- Cyclophosphamide 50 Tablets (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01AA01
CAS registry number (Chemical Abstracts Service)
0000050-18-0
Chemical Formula
C7-H15-Cl2-N2-O2-P
Molecular Weight
261
Therapeutic Categories
Disease-modifying antirheumatic drug, DMARD
Antineoplastic agent, alkylating agent
Chemical Name
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide
Foreign Names
- Cyclophosphamidum (Latin)
- Cyclophosphamid (German)
- Cyclophosphamide (French)
- Ciclofosfamida (Spanish)
Generic Names
- Cyclophosphamide (OS: DCF, BAN)
- B 518 (IS)
- CYP (IS)
- Ledoxina (IS)
- NSC 26271 (IS)
- Cyclophosphamide (PH: JP XIV, BP 2010, Ph. Int. 4, USP 30, Ph. Eur. 6)
- Ciclofosfamide (PH: Ph. Eur. 6)
- Cyclophosphamid (PH: Ph. Eur. 6, USP 32)
- Cyclophosphamide Hydrate (PH: JP XV)
- Cyclophosphamidum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Alkyloxan
Onko-Koçsel, Turkey
- Biodoxan
Biogalenic, Venezuela
- Ciclofosfamida Dosa
Dosa, Argentina
- Ciclofosfamida Filaxis
Filaxis, Argentina
- Ciclofosfamida L.CH.
Chile, Chile
- Ciclofosfamida Martian
LKM, Argentina
- Ciclofosfamida Microsules
Microsules, Argentina
- Ciclofosfamida
Bestpharma, Chile; Kampar, Chile; Palmagyar, Peru; World Pharma, Peru
- Cycloblastin
Pfizer, Australia
- Cyclogal
Galenika, Serbia
- Cyclophosphamid A-Pharma
Baxter, Denmark
- Cyclophosphamide
Baxter, United States; Kalbe, Indonesia; Roxane, United States
- Cyclophosphan-Lens
Verofarm, Georgia
- Cyclovid
Novell, Indonesia
- Cycloxan
Biochem, India
- Cycram
Korea United Pharm, Georgia
- Cyloblastin
Pfizer, New Zealand
- Cytophosphan
Taro, Israel
- Cytoxan
Baxter Healthcare, United States; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Serbia
- Endoxan Baxter
Baxter, Austria
- Endoxan
All-Gen, Netherlands; ASTA Medica, Bangladesh; ASTA Medica, Tunisia; Aventis, South Africa; Baxter, Australia; Baxter, Belgium; Baxter, Chile; Baxter, France; Baxter, Hong Kong; Baxter, Israel; Baxter, Lithuania; Baxter, Luxembourg; Baxter, Latvia; Baxter, Netherlands; Baxter, New Zealand; Baxter, Serbia; Baxter, Slovenia; Baxter, Tunisia; Baxter, Taiwan; Baxter Oncology, Oman; Baxter Oncology, Poland; Baxter Oncology, Singapore; Eczacibasi Baxter, Turkey; German Remedies, India; Transfarma Medica Indah, Indonesia
- Endoxana
ASTA Medica, Ireland; Baxter, United Arab Emirates; Baxter, Bahrain; Baxter, Egypt; Baxter, Iraq; Baxter, Iran; Baxter, Jordan; Baxter, Kuwait; Baxter, Lebanon; Baxter, Qatar; Baxter, Saudi Arabia; Baxter, Syria; Baxter, Yemen; Baxter Oncology, United Kingdom; Baxter Oncology, Oman
- Endoxana (veterinary use)
Baxter, United Kingdom
- Endoxan-Asta
ASTA Medica, United Arab Emirates; ASTA Medica, Bahrain; ASTA Medica, Cyprus; ASTA Medica, Egypt; ASTA Medica, Iraq; ASTA Medica, Jordan; ASTA Medica, Kuwait; ASTA Medica, Lebanon; ASTA Medica, Sri Lanka; ASTA Medica, Libya; ASTA Medica, Qatar; ASTA Medica, Saudi Arabia; ASTA Medica, Sudan; ASTA Medica, Syria; ASTA Medica, Yemen
- Genoxal
Baxter, Spain
- Ledoxan
Dabur, Philippines
- Ledoxina
Chile, Chile
- Oncomide
Khandelwal, Myanmar
- Procytox
Baxter, Canada
- Sendoxan
Baxter, Denmark; Baxter, Iceland
- Syklofosfamid
Atafarm, Turkey; Orion, Taiwan
- Cryofaxol
Cryopharma, Mexico
- Cyclophosphamide
Orion, Czech Republic; Pfizer, United Kingdom
- Cytoxan
Bristol-Myers Squibb, Hungary
- Endoxan Baxter
Baxter, Austria; Baxter Oncology-D, Italy
- Endoxan
Agmar, Croatia (Hrvatska); Asta Medica, Bulgaria; Baxter, Belgium; Baxter, Bulgaria; Baxter, Switzerland; Baxter, Czech Republic; Baxter, Estonia; Baxter, France; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Luxembourg; Baxter, Netherlands; Baxter, Romania; Baxter, Slovakia; Baxter, Vietnam; Baxter Oncology, Germany; Shionogi Seiyaku, Japan; Sindan, Romania
- Endoxan P
Shionogi Seiyaku, Japan
- Endoxana
Baxter, Malta
- Ledoxina
Lemery, Mexico
- Sendoxan
Baxter, Finland; Baxter, Norway; Baxter, Sweden
- Syklofosfamid
Orion, Estonia; Orion, Finland
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and
International Nonproprietary Names.